Skip to main content
Premium Trial:

Request an Annual Quote

Seattle Biomedical Research Institute Lands $30.6M to Establish Structural Genomics Center

NEW YORK (GenomeWeb News) – The Seattle Biomedical Research Institute will use a $30.6 million contract award from the National Institute for Allergy and Infectious Diseases to run a collaborative initiative aimed at using genomics and translational research methods to study a number of diseases, the institute said recently.
 
SBRI will use the five-year contract to start the Seattle Structural Genomics Center for Infectious Disease, and it will work with researchers at the University of Washington, Battelle Northwest, and Decode Biostructures, which is a subsidiary of Decode Genetics.
 
The goal of the center is to determine the three-dimensional structures of proteins from bacterial, viral, fungal, and protozoan pathogens that cause emerging and re-emerging infectious diseases, SBRI said, in order to develop a “blueprint” to be used in development of new drug treatments.
 
“By determining the three-dimensional structure of these proteins, we can identify important pockets or clefts and design small molecules which will disrupt their disease-causing function,” SBRI Principal Investigator Peter Myler said in a statement.
 
Myler aims for the center to solve 75 to 100 protein structures per year, with the results of the research being published and shared with scientists around the world.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.